Physician profile
Hyun Kim
NPI 1336180926
$17,718.76
in general payments reported to CMS, 2019-2025
12 companies · $280 in 2025
The $280 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,768 · 2020: $11K · 2021: $22.02 · 2022: $225 · 2023: $180 · 2024: $1,407 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,220 · Food and Beverage: $647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,220.00 |
| Food and Beverage | $647.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,536.63 | 2019-2024 | Interlock, Opticross 35, Embold Fibered |
| Genentech USA, INC. | $4,027.91 | 2020 | |
| Eisai INC. | $2,745.01 | 2020 | |
| Sirtex Medical INC | $2,564.24 | 2020 | |
| Merck Sharp & Dohme LLC | $1,220.00 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $370.07 | 2024-2025 | Imfinzi |
| Ekos Corporation | $118.34 | 2019 | |
| Cardiva Medical, INC. | $49.84 | 2019 | |
| Siemens Medical Solutions USA, INC. | $27.32 | 2025 | |
| Angiodynamics, INC. | $22.02 | 2021 | |
| Terumo Medical Corporation | $19.53 | 2024 | Azur Cx Detachable, Navicross, Glidewire |
| Medtronic, INC. | $17.85 | 2025 | In.Pact Admiral |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hyun Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.